Did you listen to the KOL call on Slingshot Insights a week or so ago? I am not expert by any means, but the KOL (who came across as an expert and treats HD patients) seemed pretty skeptical of AMT 130. I am not saying AMT 130 does not have potential, but it seems like there is a long road ahead. For example, has the FDA said they would accept the BLA for AMT 130 or that they are open to it? Has QURE released any SAE data? I am not trying to downplay the potential, but the KOL call raised a lot of questions about the path ahead.
Did you listen to the KOL call on Slingshot Insights a week or so ago? I am not expert by any means, but the KOL (who came across as an expert and treats HD patients) seemed pretty skeptical of AMT 130. I am not saying AMT 130 does not have potential, but it seems like there is a long road ahead. For example, has the FDA said they would accept the BLA for AMT 130 or that they are open to it? Has QURE released any SAE data? I am not trying to downplay the potential, but the KOL call raised a lot of questions about the path ahead.